Security key
00808Y406
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)
CUSIP: 00808Y406
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 1,651,503
- Total 13F shares
- 405,570
- Share change
- +224,264
- Total reported value
- $186,762
- Price per share
- $0.47
- Number of holders
- 18
- Value change
- +$101,602
- Number of buys
- 11
- Number of sells
- 7
Report period
Q3 2024
Institutions
18
Top holders
10
AEMD full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
AETHLON MEDICAL INC SEC filings
AETHLON MEDICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00808Y406
Recent filing periods:
Top shareholders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2.2%
|
36,652
|
$18,278 | — | 30 Jun 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
2.1%
|
34,544
|
$17,227 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.6%
|
26,408
|
$13,170 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
21,224
|
$10,584 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
20,274
|
$10,110 | — | 30 Jun 2024 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.8%
|
13,251
|
$5,382 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.61%
|
10,088
|
$5,000 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.44%
|
7,340
|
$3,660 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.42%
|
6,892
|
$3,439 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
1,730
|
$863 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.07%
|
1,217
|
$607 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.07%
|
1,100
|
$549 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
211
|
$105 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
199
|
$99 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
89
|
$44 | — | 30 Jun 2024 | |
| Anfield Capital Management, LLC |
13F
|
Company |
0%
|
41
|
$20 | — | 30 Jun 2024 | |
| BARTLETT & CO. WEALTH MANAGEMENT LLC |
13F
|
Company |
0%
|
26
|
$13 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
20
|
$10 | — | 30 Jun 2024 | |
| Sabrina Martucci Johnson |
3/4/5
|
Director |
—
class O/S missing
|
33,642
|
$73,676 | — | 31 Mar 2022 | |
| Charles J. Fisher Jr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
192,600
|
— | — | 10 Feb 2022 | |
| Guy F. Cipriani |
3/4/5
|
Sr. V.P., Chief Bus. Officer, Director |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| James B. Frakes |
3/4/5
|
CFO & Sr. VP ? Finance |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| Steven P. Larosa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| Lee D. Arnold |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
60,620
|
— | — | 01 Feb 2023 |
Institutional Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q3 2024
As of 30 Sep 2024,
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
405,570 shares.
The largest 10 holders included
UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Baader Bank Aktiengesellschaft, TWO SIGMA INVESTMENTS, LP, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., CITIGROUP INC, and JPMORGAN CHASE & CO.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
18
Q3 2024 holders
18
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.